NVIDIA's AI platforms impacting MedTech digital advancements with Resmed, GE HealthCare, and Medtronic

From NASDAQ.: 2025-03-13 10:35:00

Zacks.com highlights NVIDIA, Resmed, GE HealthCare, and Medtronic in their Analyst Blog, focusing on the impact of NVIDIA’s AI platform on MedTech’s digital advancements.

NVIDIA’s generative AI platforms like Clara and BioNeMo are revolutionizing medical imaging and drug discovery. MedTech leaders like Resmed, GE HealthCare, and Medtronic are integrating AI into devices for autonomous data analysis and precise treatment delivery.

MedTech is quickly adapting to AI to address a projected 11 million health worker shortfall by 2030. Regulatory bodies are evolving to approve AI-enabled devices faster, leading to industry-wide adoption and safety standards maintenance.

Resmed, with a $34.8 billion market cap, is expanding AI products like AirView for better healthcare by 2030. GE HealthCare’s AI applications in clinical decision support and personalized therapies are driving growth, while Medtronic integrates AI for improved clinical outcomes.



Read more at NASDAQ.: The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare and Medtronic